Manufacturing Today Issue 205 Issue 205 - October 2022 | Page 91

Envair Technology

NEXT GENERATION

CONTAINMENT

How combined expertise is fueling Envair Technology ’ s international growth

Pharmaceutical manufacturing is a complex and rapidly evolving industry . Manufacturers have adapted their production lines , as they aim to speed up processes to meet increasing demands for the faster development of highly personalized treatments – such as Antibody Drug Conjugates ( ADCs ), targeted medicines that deliver chemotherapy agents directly to cancer cells .

Many of them are also working with Highly Potent Active Pharmaceutical Ingredients ( HPAPIs ) which , when used in microscopic doses , enable a targeted approach to treatment .
These are life-changing developments , but their complex nature has also created challenges around manufacturing control – with cross-contamination risks and danger to operators who are handling these substances . Demand for clean air and containment solutions has therefore grown , as manufacturers look to ensure that their workers are protected during the drug production process .
Responding to this demand , Envair Technology was formed by uniting three businesses operating in the clean air and containment space – flexible isolator specialist , ONFAB , rigid isolator manufacturer , Envair , and Total Containment Solutions ( TCS ), which is a leading supplier of fume cupboards . Each brand boasts its own unique heritage , with Envair celebrating its 50th anniversary this year .
As a group , Envair Technology provides solutions at every stage of the value chain for pharmaceutical companies - covering the full lifecycle of drug manufacture , from research into candidate compounds for clinical trials through to manufacture , and dispensing within hospitals .
Following significant growth over the past two years , Envair Technology now employs 150 people . With a turnover in excess of £ 20 million , it offers the widest portfolio of clean air and containment solutions to facilitate drug development and manufacturing in the pharmaceutical sector .
Pooling resources to drive innovation
Much of Envair Technology ’ s success is a result of how it has harnessed skillsets from across the merged businesses and brought more of the group ’ s operations under one roof – increasing
manufacturing-today . com 89